How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your biological predispositions in GLP-1 and appetite-regulation pathways
[1] [2] While originally developed for type 2 diabetes management under the brand name Ozempic, a higher-dose formulation marketed as Wegovy received FDA approval specifically for weight management in 2021
GPs can conduct initial assessments using validated tools such as the AUDIT (Alcohol Use Disorders Identification Test), provide brief interventions for hazardous drinking, and refer to specialist services when appropriate
If you are currently prescribed HGH by an NHS endocrinologist or specialist and are considering adding any other agent including retatrutide or other GLP-1-based medicines it is essential to discuss this with your prescribing clinician before making any changes
Disclaimer Not Evaluated by the FDA for All Uses These statements may not be reviewed by the FDA, and methylcobalamin injections are not FDA-approved to diagnose, treat, cure, or prevent any disease beyond recognized indications